Glaukos Announces Presentation Cancellation at the William Blair 40th Annual Growth Stock Conference
June 09 2020 - 6:30PM
Business Wire
Glaukos Corporation (NYSE: GKOS), an ophthalmic
medical technology and pharmaceutical company focused on novel
therapies for the treatment of glaucoma, corneal disorders and
retinal diseases, today announced that in light of the company’s
offering of its 2.75% Convertible Senior Notes due 2027, which is
expected to close on June 11, 2020, subject to customary closing
conditions, management will no longer be participating in its
previously announced virtual fireside presentation and associated
webcast at the William Blair 40th Annual Growth Stock Conference,
previously scheduled for Wednesday, June 10, 2020, at 3:20 p.m.
CDT. Management will continue to participate in the conference’s
other investor forums.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology
and pharmaceutical company focused on novel therapies for the
treatment of glaucoma, corneal disorders and retinal diseases. The
company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to
revolutionize the traditional glaucoma treatment and management
paradigm. Glaukos launched the iStent®, its first MIGS device, in
the United States in July 2012 and launched its next-generation
iStent inject® device in the United States in September 2018. In
corneal health, Glaukos’ proprietary suite of single-use,
bio-activated pharmaceuticals are designed to strengthen, stabilize
and reshape the cornea through a process called corneal collagen
cross-linking to treat corneal ectatic disorders and correct
refractive conditions. Glaukos is leveraging its platform
technology to build a comprehensive and proprietary portfolio of
micro-scale surgical and pharmaceutical therapies in glaucoma,
corneal health and retinal disease.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200609005834/en/
Chris Lewis Director, Investor Relations, Corporate Strategy
& Development (949) 481-0510 clewis@glaukos.com
Glaukos (NYSE:GKOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Glaukos (NYSE:GKOS)
Historical Stock Chart
From Apr 2023 to Apr 2024